FI

FINOVATIS

Grant-FundedCORDIS

Monoclonal Antibodies against 2019-New Coronavirus

Visit website
🇫🇷 Lyon, France·finovatis.com
Biotech · SaaS
FINOVATIS is a private SME recorded in CORDIS in France, with participation in 9 EU research and innovation projects. Its recorded projects include “Monoclonal Antibodies against 2019-New Coronavirus”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
EU Grants€2,033,253
All-time revenue—
MRRPrivate••••••
Founder—
Founded—
🇫🇷France
RevenuePrivate
Revenue data is privateThis company has chosen not to share revenue metrics

Startup insights

Value proposition

FINOVATIS is a private SME recorded in CORDIS in France, with participation in 9 EU research and innovation projects. Its recorded projects include “Monoclonal Antibodies against 2019-New Coronavirus”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.

BiotechSaaS
Tags:BiotechSaaS

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime